180 related articles for article (PubMed ID: 9407126)
1. The catalytic domain of protein kinase Cdelta confers protection from down-regulation induced by bryostatin 1.
Lorenzo PS; Bögi K; Acs P; Pettit GR; Blumberg PM
J Biol Chem; 1997 Dec; 272(52):33338-43. PubMed ID: 9407126
[TBL] [Abstract][Full Text] [Related]
2. Differential roles of the tandem C1 domains of protein kinase C delta in the biphasic down-regulation induced by bryostatin 1.
Lorenzo PS; Bögi K; Hughes KM; Beheshti M; Bhattacharyya D; Garfield SH; Pettit GR; Blumberg PM
Cancer Res; 1999 Dec; 59(24):6137-44. PubMed ID: 10626804
[TBL] [Abstract][Full Text] [Related]
3. Bryostatin 1 protects protein kinase C-delta from down-regulation in mouse keratinocytes in parallel with its inhibition of phorbol ester-induced differentiation.
Szallasi Z; Denning MF; Smith CB; Dlugosz AA; Yuspa SH; Pettit GR; Blumberg PM
Mol Pharmacol; 1994 Nov; 46(5):840-50. PubMed ID: 7969070
[TBL] [Abstract][Full Text] [Related]
4. Both the catalytic and regulatory domains of protein kinase C chimeras modulate the proliferative properties of NIH 3T3 cells.
Acs P; Wang QJ; Bögi K; Marquez AM; Lorenzo PS; Bíró T; Szállási Z; Mushinski JF; Blumberg PM
J Biol Chem; 1997 Nov; 272(45):28793-9. PubMed ID: 9353351
[TBL] [Abstract][Full Text] [Related]
5. Differential regulation of protein kinase C isozymes by bryostatin 1 and phorbol 12-myristate 13-acetate in NIH 3T3 fibroblasts.
Szallasi Z; Smith CB; Pettit GR; Blumberg PM
J Biol Chem; 1994 Jan; 269(3):2118-24. PubMed ID: 8294465
[TBL] [Abstract][Full Text] [Related]
6. Enhancement of cisplatin sensitivity of cisplatin-resistant human cervical carcinoma cells by bryostatin 1.
Mohanty S; Huang J; Basu A
Clin Cancer Res; 2005 Sep; 11(18):6730-7. PubMed ID: 16166454
[TBL] [Abstract][Full Text] [Related]
7. Protein kinase C delta (PKCdelta) inhibits the expression of glutamine synthetase in glial cells via the PKCdelta regulatory domain and its tyrosine phosphorylation.
Brodie C; Bogi K; Acs P; Lorenzo PS; Baskin L; Blumberg PM
J Biol Chem; 1998 Nov; 273(46):30713-8. PubMed ID: 9804846
[TBL] [Abstract][Full Text] [Related]
8. Bryostatin 1 and phorbol ester down-modulate protein kinase C-alpha and -epsilon via the ubiquitin/proteasome pathway in human fibroblasts.
Lee HW; Smith L; Pettit GR; Smith JB
Mol Pharmacol; 1997 Mar; 51(3):439-47. PubMed ID: 9058599
[TBL] [Abstract][Full Text] [Related]
9. Dephosphorylation of activated protein kinase C contributes to downregulation by bryostatin.
Lee HW; Smith L; Pettit GR; Bingham Smith J
Am J Physiol; 1996 Jul; 271(1 Pt 1):C304-11. PubMed ID: 8760059
[TBL] [Abstract][Full Text] [Related]
10. Activation of T-cells by bryostatins: induction of the IL-2 receptor gene transcription and down-modulation of surface receptors.
Esa AH; Boto WO; Adler WH; May WS; Hess AD
Int J Immunopharmacol; 1990; 12(5):481-90. PubMed ID: 2210911
[TBL] [Abstract][Full Text] [Related]
11. Tumor promotion by depleting cells of protein kinase C delta.
Lu Z; Hornia A; Jiang YW; Zang Q; Ohno S; Foster DA
Mol Cell Biol; 1997 Jun; 17(6):3418-28. PubMed ID: 9154841
[TBL] [Abstract][Full Text] [Related]
12. Protein kinase C chimeras: catalytic domains of alpha and beta II protein kinase C contain determinants for isotype-specific function.
Walker SD; Murray NR; Burns DJ; Fields AP
Proc Natl Acad Sci U S A; 1995 Sep; 92(20):9156-60. PubMed ID: 7568092
[TBL] [Abstract][Full Text] [Related]
13. Involvement of protein kinase Cdelta in contact-dependent inhibition of growth in human and murine fibroblasts.
Heit I; Wieser RJ; Herget T; Faust D; Borchert-Stuhlträger M; Oesch F; Dietrich C
Oncogene; 2001 Aug; 20(37):5143-54. PubMed ID: 11526503
[TBL] [Abstract][Full Text] [Related]
14. The effect of bryostatin on protein kinase C-regulated functions in human T lymphocytes and epidermal keratinocytes.
Galron D; Tamir A; Gelkop S; Grossman N; Isakov N
Immunol Lett; 1993 Dec; 39(1):17-22. PubMed ID: 8144186
[TBL] [Abstract][Full Text] [Related]
15. Bryostatin 1 induces prolonged activation of extracellular regulated protein kinases in and apoptosis of LNCaP human prostate cancer cells overexpressing protein kinase calpha.
Gschwend JE; Fair WR; Powell CT
Mol Pharmacol; 2000 Jun; 57(6):1224-34. PubMed ID: 10825394
[TBL] [Abstract][Full Text] [Related]
16. Bryostatin 1 inhibits phorbol ester-induced apoptosis in prostate cancer cells by differentially modulating protein kinase C (PKC) delta translocation and preventing PKCdelta-mediated release of tumor necrosis factor-alpha.
von Burstin VA; Xiao L; Kazanietz MG
Mol Pharmacol; 2010 Sep; 78(3):325-32. PubMed ID: 20516369
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of phorbol ester-induced T cell proliferation by bryostatin is associated with rapid degradation of protein kinase C.
Isakov N; Galron D; Mustelin T; Pettit GR; Altman A
J Immunol; 1993 Feb; 150(4):1195-204. PubMed ID: 8432975
[TBL] [Abstract][Full Text] [Related]
18. Protein kinase C isotypes in human erythroleukemia cell proliferation and differentiation.
Hocevar BA; Morrow DM; Tykocinski ML; Fields AP
J Cell Sci; 1992 Mar; 101 ( Pt 3)():671-9. PubMed ID: 1522149
[TBL] [Abstract][Full Text] [Related]
19. Differential effect of bryostatin 1 and phorbol 12-myristate 13-acetate on HOP-92 cell proliferation is mediated by down-regulation of protein kinase Cdelta.
Choi SH; Hyman T; Blumberg PM
Cancer Res; 2006 Jul; 66(14):7261-9. PubMed ID: 16849575
[TBL] [Abstract][Full Text] [Related]
20. Delta-protein kinase C phosphorylation parallels inhibition of nerve growth factor-induced differentiation independent of changes in Trk A and MAP kinase signalling in PC12 cells.
Wooten MW; Seibenhener ML; Heikkila JE; Mischak H
Cell Signal; 1998 Apr; 10(4):265-76. PubMed ID: 9617484
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
